Industry Applauds FDA Plan For Faster Cancer-Drug Review
Review But many critics are urging still other changes, including easier approval of 'off-label' uses DÉJÀ VU: NCI's David Parkinson sees parallels with AIDS drug testing. By Oncologists, industry officials, and cancer-patient advocacy organizations are applauding recently announced policy changes at the Food and Drug Administration (FDA) that speed up the approval process for cancer drugs. The plan, announced on March 29 by President Bill Clinton, aims to immediately streamlin
Apr 28, 1996
Review But many critics are urging still other changes, including easier approval of 'off-label' uses
![]() DÉJÀ VU: NCI's David Parkinson sees parallels with AIDS drug testing. |
Proponents of the changes contend they will expedite patients' access to potentially life-saving medications.
![]() STEPPING UP: Jefferson University's Robert Comis supports reform. |
Interested in reading more?
Become a Member of
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member?